Bayer gets FDA approval for two additional requests for testing BNP
Bayer HealthCare LLC, Diagnostic, a member of the Bayer Group (NYSE: BAY), announced that BNP test has received U.S. Food and Drug Administration (FDA) approval of two additional questions - the prediction of survival in patients after myocardial infarction or heart attack in combination with other risk factors and assessing the severity of heart failure in patients with diagnosis of congestive heart failure. The fully automated BNP test, first described as an aid in the diagnosis of heart failure in 2003, is available for use on the ADVIA Centaur and ACS: 180 Immunoassay System.While today more people survive heart attacks are, many of them from developing heart failure, said Dr. David Morrow, Brigham and Womens Hospital in Boston, Massachusetts. We found that the use of
this simple blood test upon arrival at the hospital, both for our standard tools for assessing patients risk of death or development of heart failure. Dr. Morrow was one of the principal investigators of the TIMI-23 study, which used to be the elements of the filing of the Bayer BNP test provided.There were no significant differences in the values ​​of BNP in normal subjects than in patients with heart failure of four New York Heart Association (NYHA) classes, including the less serious class I. The proportional increase in the concentration of BNP is approximately 2-fold increases the severity of heart failure class I to II, II and III, III-IV. This differentiation has led the FDA clearing the Bayer BNP test as an instrument for the assessment of severity in patients
with heart failure. Bayer Diagnostics is committed to improving the situation of cardiovascular diseases.The increase in heart failure has reached epidemic proportions worldwide concerns, reached over 18 million people, Hans Hiller, Ph.D., director of diagnostic test systems, said Professional. The BNP test is an integral part of care for patients with known or suspected heart failure. It is a simple, accurate and inexpensive Pages: [1] 2 3